These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15629333)

  • 21. Corticosteroid eyedrops and intra-ocular pressure.
    Drug Ther Bull; 1968 Mar; 6(5):18-9. PubMed ID: 5649585
    [No Abstract]   [Full Text] [Related]  

  • 22. Letter to the editor: patient persistency with glaucoma therapy.
    Fiscella R; Stewart WC
    J Ocul Pharmacol Ther; 2005 Aug; 21(4):349-50; author reply 350-2. PubMed ID: 16117699
    [No Abstract]   [Full Text] [Related]  

  • 23. A comprehensive perspective on patient adherence to topical glaucoma therapy.
    Tsai JC
    Ophthalmology; 2009 Nov; 116(11 Suppl):S30-6. PubMed ID: 19837258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.
    Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA
    Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glaucoma medications. How to improve compliance and adherence.
    Cakiner-Egilmez T; Lara-Smalling A
    Insight; 2012; 37(2):5-9; quiz 10. PubMed ID: 22685875
    [No Abstract]   [Full Text] [Related]  

  • 26. Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy.
    Lewis RA; Katz GJ; Weiss MJ; Landry TA; Dickerson JE; James JE; Hua SY; Sullivan EK; Montgomery DB; Wells DT; Bergamini MV;
    J Glaucoma; 2007 Jan; 16(1):98-103. PubMed ID: 17224758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chart documentation by general physicians of the glaucoma medications taken by their patients.
    Jampel HD; Parekh P; Johnson E; Miller R
    Am J Ophthalmol; 2005 Aug; 140(2):344-5. PubMed ID: 16086971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Keep an eye out for glaucoma.
    Kowing D; Kester E
    Nurse Pract; 2007 Jul; 32(7):18-23; quiz 23-4. PubMed ID: 17595584
    [No Abstract]   [Full Text] [Related]  

  • 29. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC; Konstas AG; Nelson LA; Kruft B
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy.
    Soltau JB
    J Glaucoma; 2004 Aug; 13(4):348; author reply 348. PubMed ID: 15226666
    [No Abstract]   [Full Text] [Related]  

  • 31. [Topical prostaglandins influence over cornea--preliminary report].
    Wierzbowska J; Stankiewicz A
    Klin Oczna; 2006; 108(10-12):479-81. PubMed ID: 17455732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corneal sensitivity changes following the instillation of latanoprost, bimatoprost, and travoprost eyedrops.
    Kozobolis VP; Detorakis ET; Maskaleris G; Koukoula SC; Fountoulakis N; Chrysochoou F; Konstas AG
    Am J Ophthalmol; 2005 Apr; 139(4):742-3. PubMed ID: 15808188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study.
    Quigley HA; Friedman DS; Hahn SR
    Ophthalmology; 2007 Sep; 114(9):1599-606. PubMed ID: 17572498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should patients choose their own eyedrops?
    Buller A; Hercules BL
    Acta Ophthalmol Scand; 2006 Feb; 84(1):150-1. PubMed ID: 16445459
    [No Abstract]   [Full Text] [Related]  

  • 35. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glaucoma patient expression of medication problems and nonadherence.
    Slota C; Sayner R; Vitko M; Carpenter DM; Blalock SJ; Robin AL; Muir KW; Hartnett ME; Sleath B
    Optom Vis Sci; 2015 May; 92(5):537-43. PubMed ID: 25875690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug therapy in the treatment of glaucoma].
    Thieme H
    Klin Monbl Augenheilkd; 2006 Sep; 223(9):R73-8; quiz R79-80. PubMed ID: 16986080
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension.
    Schuman JS; Katz GJ; Lewis RA; Henry JC; Mallick S; Wells DT; Sullivan EK; Landry TA; Bergamini MV; Robertson SM
    Am J Ophthalmol; 2005 Aug; 140(2):242-50. PubMed ID: 16086946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical treatment of glaucoma: present and future.
    Fogagnolo P; Rossetti L
    Expert Opin Investig Drugs; 2011 Jul; 20(7):947-59. PubMed ID: 21534887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Medicinal therapy and course control of glaucoma. Options and limits of local therapy].
    Diestelhorst M
    Ophthalmologe; 2013 Dec; 110(12):1132-3. PubMed ID: 24337204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.